This is our
PORTFOLIO
with which we are 100% transparent.
Since 2015 we have built a diversified portfolio with growing value. We put a lot of work and specialized knowledge into selecting the best investment opportunities - that's why we only publish approximately 3% of the ones we analyze.
In co-investment
Direct investment
Investee companies
In business
187.000€
Round size
May 2017
Date
MedTech
Sector
296.000€
Round size
April 2017
Date
Drug discovery
Sector
600.000€
Round size
December 2016
Date
Bioinformatics
Sector
91.000€
Round size
October 2016
Date
Test
Sector
374.000€
Round size
May 2016
Date
Bioinformatics
Sector
201.000€
Round size
April 2016
Date
MedTech
Sector
151.000€
Round size
December 2015
Date
Software
Sector
600.000€
Round size
March 2015
Date
Drug discovery
Sector
£850,000
Round size
February 2018
Date
Diagnostics
Sector
£450,000
Round size
March 2018
Date
Medical Device
Sector
All the investment opportunities we publish on Capital Cell have a reference investor who has conducted its own analysis, its own Due Diligence and validated the price per share. This reinforces our confidence that the project and its team are capable of generating a return.
Some benchmark investors of companies we have published:
